{"id":19521,"date":"2024-12-09T10:52:53","date_gmt":"2024-12-09T09:52:53","guid":{"rendered":"https:\/\/actubusinessangels.com\/?p=19521"},"modified":"2024-12-09T10:52:53","modified_gmt":"2024-12-09T09:52:53","slug":"odimma-therapeutics-et-ses-avancees-majeures","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/odimma-therapeutics-et-ses-avancees-majeures\/","title":{"rendered":"Odimma Therapeutics et ses avanc\u00e9es majeures"},"content":{"rendered":"\n<p class=\"has-text-align-justify\">Le Dr <strong>Jean-Marc Limacher<\/strong>, Directeur des Affaires M\u00e9dicales chez <strong><a href=\"https:\/\/www.odimma-therapeutics.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Odimma Therapeutics<\/a><\/strong> fut invit\u00e9 dans l&#8217;\u00e9mission <strong><a href=\"https:\/\/iglooonair.com\/igloo-on-air\/\" target=\"_blank\" rel=\"noreferrer noopener\">Igloo on Air<\/a><\/strong> au c\u00f4t\u00e9 de <strong>C\u00e9dric Simonin <\/strong>associ\u00e9 d&#8217;Odimma Therapeutics. Anim\u00e9 par <strong>Eric Genetet<\/strong>, cet \u00e9change relate l&#8217;\u00e9volution de l&#8217;entreprise et pr\u00e9sente ses avanc\u00e9es majeures dans le secteur de la sant\u00e9. Cette entreprise est soutenue par des r\u00e9seaux de Business Angels dont <strong><a href=\"https:\/\/www.alsacebusinessangels.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Alsace Business Angels<\/a><\/strong> et <strong><a href=\"https:\/\/www.angelssante.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Angels Sant\u00e9<\/a><\/strong>.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p class=\"has-text-align-justify\">Tout au long de cette \u00e9mission, Odimma r\u00e9v\u00e8le une <strong>d\u00e9couverte majeure sur le d\u00e9veloppement d&#8217;un vaccin contre la variole du singe<\/strong> (Mpox), une avanc\u00e9e cruciale dans la lutte contre cette maladie virale. Cette d\u00e9couverte est issue de la recherche contre le cancer colorectal. Vous apprendrez \u00e9galement dans cette interview comment les recherches men\u00e9es pour le vaccin contre le cancer colorectal ont permis de d\u00e9velopper une solution vaccinale contre la variole du singe. Le lien entre ces deux domaines de recherche a \u00e9t\u00e9 identifi\u00e9 gr\u00e2ce \u00e0 une d\u00e9marche scientifique novatrice. <\/p>\n\n\n\n<p class=\"has-text-align-justify\">Le Dr Limacher explique comment <strong>Odimma a su r\u00e9pondre rapidement \u00e0 l\u2019urgence sanitaire provoqu\u00e9e par l\u2019\u00e9pid\u00e9mie mondiale de Mpox<\/strong>. Ce vaccin prometteur est une r\u00e9ponse efficace pour contenir cette crise de sant\u00e9 publique \u00e0 l\u2019\u00e9chelle internationale. Il r\u00e9pond \u00e9galement aux questions sur l&#8217;<strong>impact globale et les perspectives d&#8217;avenir<\/strong> et sur les <strong>r\u00e9percussions mondiales de ce vaccin sur la gestion mondiale de cette \u00e9pid\u00e9mie<\/strong>.<\/p>\n\n\n\n<p>D\u00e9couvrez l&#8217;int\u00e9gralit\u00e9 de l&#8217;interview sur ce <strong><a href=\"https:\/\/www.youtube.com\/watch?v=ubT3tJug_nk\" target=\"_blank\" rel=\"noreferrer noopener\">lien<\/a><\/strong> !<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p class=\"has-text-align-justify\">Pour rappel, Odimma Therapeutic est une <strong>soci\u00e9t\u00e9 de biotechnologie fran\u00e7aise qui propose une approche unique en mati\u00e8re d\u2019immunoth\u00e9rapie active personnalis\u00e9e contre le cancer<\/strong>. L\u2019immunoth\u00e9rapie a r\u00e9volutionn\u00e9 le traitement de nombreux cancers avanc\u00e9s. Malgr\u00e9 cette avanc\u00e9e \u00e9tonnante, les b\u00e9n\u00e9fices cliniques significatifs sont encore limit\u00e9s \u00e0 10 \u00e0 30 % des patients. Odimma croit en l\u2019avenir de la m\u00e9decine de pr\u00e9cision et s\u2019appuie sur les avanc\u00e9es r\u00e9centes dans le domaine de l\u2019immuno-oncologie pour amplifier l\u2019efficacit\u00e9 des th\u00e9rapies actuelles, am\u00e9liorant ainsi la vie et rendant chaque patient unique. <\/p>\n<\/blockquote>\n\n\n\n<p class=\"has-text-align-justify\">En exploitant la capacit\u00e9 du syst\u00e8me immunitaire du patient \u00e0 reconna\u00eetre sp\u00e9cifiquement les cibles non-auto-immunes affich\u00e9es par la tumeur, \u00e9galement appel\u00e9es n\u00e9oantig\u00e8nes, <strong>Odimma a con\u00e7u une plateforme d\u2019immunisation personnalis\u00e9e de nouvelle g\u00e9n\u00e9ration qui apporte une solution th\u00e9rapeutique durable pour lutter contre les cancers les plus difficiles \u00e0 traiter.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Dr Jean-Marc Limacher, Directeur des Affaires M\u00e9dicales chez Odimma Therapeutics fut invit\u00e9 dans l&#8217;\u00e9mission Igloo on Air au c\u00f4t\u00e9 de C\u00e9dric Simonin associ\u00e9 d&#8217;Odimma Therapeutics. Anim\u00e9 par Eric Genetet, cet \u00e9change relate l&#8217;\u00e9volution de l&#8217;entreprise et pr\u00e9sente ses avanc\u00e9es majeures dans le secteur de la sant\u00e9. Cette entreprise est soutenue par des r\u00e9seaux de&hellip;<\/p>\n","protected":false},"author":114,"featured_media":19531,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[158,87],"tags":[214,147,63,1354,1355,1356,1357,1358,1030,76,93],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.7.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Odimma Therapeutics et ses avanc\u00e9es majeures - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Odimma Therapeutics et ses avanc\u00e9es majeures - France Angels\" \/>\n<meta property=\"og:description\" content=\"Le Dr Jean-Marc Limacher, Directeur des Affaires M\u00e9dicales chez Odimma Therapeutics fut invit\u00e9 dans l&#8217;\u00e9mission Igloo on Air au c\u00f4t\u00e9 de C\u00e9dric Simonin associ\u00e9 d&#8217;Odimma Therapeutics. Anim\u00e9 par Eric Genetet, cet \u00e9change relate l&#8217;\u00e9volution de l&#8217;entreprise et pr\u00e9sente ses avanc\u00e9es majeures dans le secteur de la sant\u00e9. Cette entreprise est soutenue par des r\u00e9seaux de&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-09T09:52:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2024\/12\/visuels-blog-newsletter-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Odimma Therapeutics et ses avanc\u00e9es majeures\",\"datePublished\":\"2024-12-09T09:52:53+00:00\",\"dateModified\":\"2024-12-09T09:52:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\"},\"wordCount\":420,\"commentCount\":1591,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Alsace Business Angels\",\"Angels Sant\u00e9\",\"Business Angels\",\"C\u00e9dric Simonin\",\"Eric Genetet\",\"Igloo on Air\",\"Jean-Marc Limacher\",\"Odimma\",\"Odimma Therapeutics\",\"R\u00e9seaux de Business Angels\",\"Start-up\"],\"articleSection\":[\"L'\u00e9cosyst\u00e8me\",\"La start-up du mois\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\",\"name\":\"Odimma Therapeutics et ses avanc\u00e9es majeures - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2024-12-09T09:52:53+00:00\",\"dateModified\":\"2024-12-09T09:52:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Odimma Therapeutics et ses avanc\u00e9es majeures\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Odimma Therapeutics et ses avanc\u00e9es majeures - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/","og_locale":"en_US","og_type":"article","og_title":"Odimma Therapeutics et ses avanc\u00e9es majeures - France Angels","og_description":"Le Dr Jean-Marc Limacher, Directeur des Affaires M\u00e9dicales chez Odimma Therapeutics fut invit\u00e9 dans l&#8217;\u00e9mission Igloo on Air au c\u00f4t\u00e9 de C\u00e9dric Simonin associ\u00e9 d&#8217;Odimma Therapeutics. Anim\u00e9 par Eric Genetet, cet \u00e9change relate l&#8217;\u00e9volution de l&#8217;entreprise et pr\u00e9sente ses avanc\u00e9es majeures dans le secteur de la sant\u00e9. Cette entreprise est soutenue par des r\u00e9seaux de&hellip;","og_url":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2024-12-09T09:52:53+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2024\/12\/visuels-blog-newsletter-1.jpg","type":"image\/jpeg"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Odimma Therapeutics et ses avanc\u00e9es majeures","datePublished":"2024-12-09T09:52:53+00:00","dateModified":"2024-12-09T09:52:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/"},"wordCount":420,"commentCount":1591,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Alsace Business Angels","Angels Sant\u00e9","Business Angels","C\u00e9dric Simonin","Eric Genetet","Igloo on Air","Jean-Marc Limacher","Odimma","Odimma Therapeutics","R\u00e9seaux de Business Angels","Start-up"],"articleSection":["L'\u00e9cosyst\u00e8me","La start-up du mois"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/","url":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/","name":"Odimma Therapeutics et ses avanc\u00e9es majeures - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2024-12-09T09:52:53+00:00","dateModified":"2024-12-09T09:52:53+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/odimma-therapeutics-et-ses-avancees-majeures\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Odimma Therapeutics et ses avanc\u00e9es majeures"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/19521"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=19521"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/19521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/19531"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=19521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=19521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=19521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}